Cerebral protection devices for transcatheter aortic valve replacement

Area of Science:

• Cardiovascular Medicine
• Neurology
• Medical Device Technology

Background:

• Stroke is a significant complication of transcatheter aortic valve implantation (TAVI), impacting long-term cognitive function even with subclinical brain lesions.
• Developing effective stroke prevention strategies, including embolic protection devices, is crucial for TAVI procedures.
• These devices are designed to mitigate the risk of cerebral embolization during TAVI.

Purpose of the Study:

• To review the incidence and mechanisms of neurologic events during TAVI.
• To explore the design and initial human use of cerebral embolic protection devices in TAVI.
• To analyze major clinical trials focusing on the safety and efficacy of these neuroprotective devices.

Main Methods:

• Literature review of neurologic events in TAVI.
• Analysis of cerebral embolic protection device designs and early clinical data.
• Systematic review of clinical trials evaluating TAVI neuroprotection devices.

Main Results:

• Overview of neurologic event rates and underlying mechanisms in TAVI.
• Description of various embolic protection device designs and their application in TAVI.
• Summary of clinical trial outcomes regarding safety, efficacy, and other results of neuroprotection during TAVI.

Conclusions:

• Neuroprotection during TAVI is increasingly important as the procedure expands to lower-risk populations.
• Preventing procedure-related cerebral injury may reduce long-term morbidity and mortality in TAVI patients.
• Further research and clinical adoption of effective embolic protection devices are warranted.